Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 11Prostatic Neoplasms 10Lymphoma 9Leukemia, Monocytic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Myelomonocytic, Acute 7Congenital Abnormalities 7Lymphoma, Follicular 6Leukemia, Megakaryoblastic, Acute 6Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Leukemia, Biphenotypic, Acute 5Recurrence 3Sarcoma, Myeloid 2Neoplasms 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Waldenstrom Macroglobulinemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Myeloid Malignancies 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, T-Cell 1

Interventions

venetoclax 1magrolimab 1cc-486 1Mitoxantrone 1Etoposide 1Cytarabine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Myeloid Malignancies × Mitoxantrone × Clear all
NCT04778410 2025-03-20

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Gilead Sciences

Phase 2 Terminated
54 enrolled 26 charts

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡